950 related articles for article (PubMed ID: 27115954)
1. Unplugging Mucus in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.
Mall MA
Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S177-85. PubMed ID: 27115954
[TBL] [Abstract][Full Text] [Related]
2. Airway mucus, inflammation and remodeling: emerging links in the pathogenesis of chronic lung diseases.
Zhou-Suckow Z; Duerr J; Hagner M; Agrawal R; Mall MA
Cell Tissue Res; 2017 Mar; 367(3):537-550. PubMed ID: 28108847
[TBL] [Abstract][Full Text] [Related]
3. Lack of neutrophil elastase reduces inflammation, mucus hypersecretion, and emphysema, but not mucus obstruction, in mice with cystic fibrosis-like lung disease.
Gehrig S; Duerr J; Weitnauer M; Wagner CJ; Graeber SY; Schatterny J; Hirtz S; Belaaouaj A; Dalpke AH; Schultz C; Mall MA
Am J Respir Crit Care Med; 2014 May; 189(9):1082-92. PubMed ID: 24678594
[TBL] [Abstract][Full Text] [Related]
4. Cystic Fibrosis Transmembrane Conductance Regulator: Roles in Chronic Obstructive Pulmonary Disease.
Dransfield M; Rowe S; Vogelmeier CF; Wedzicha J; Criner GJ; Han MK; Martinez FJ; Calverley P
Am J Respir Crit Care Med; 2022 Mar; 205(6):631-640. PubMed ID: 34982651
[TBL] [Abstract][Full Text] [Related]
5. Airway mucus obstruction triggers macrophage activation and matrix metalloproteinase 12-dependent emphysema.
Trojanek JB; Cobos-Correa A; Diemer S; Kormann M; Schubert SC; Zhou-Suckow Z; Agrawal R; Duerr J; Wagner CJ; Schatterny J; Hirtz S; Sommerburg O; Hartl D; Schultz C; Mall MA
Am J Respir Cell Mol Biol; 2014 Nov; 51(5):709-20. PubMed ID: 24828142
[TBL] [Abstract][Full Text] [Related]
6. The epithelial sodium channel (ENaC) as a therapeutic target for cystic fibrosis lung disease.
Moore PJ; Tarran R
Expert Opin Ther Targets; 2018 Aug; 22(8):687-701. PubMed ID: 30028216
[TBL] [Abstract][Full Text] [Related]
7. Early cystic fibrosis lung disease: Role of airway surface dehydration and lessons from preventive rehydration therapies in mice.
Mall MA; Graeber SY; Stahl M; Zhou-Suckow Z
Int J Biochem Cell Biol; 2014 Jul; 52():174-9. PubMed ID: 24561284
[TBL] [Abstract][Full Text] [Related]
8. Role of the amiloride-sensitive epithelial Na+ channel in the pathogenesis and as a therapeutic target for cystic fibrosis lung disease.
Mall MA
Exp Physiol; 2009 Feb; 94(2):171-4. PubMed ID: 19060118
[TBL] [Abstract][Full Text] [Related]
9. Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice.
Mall M; Grubb BR; Harkema JR; O'Neal WK; Boucher RC
Nat Med; 2004 May; 10(5):487-93. PubMed ID: 15077107
[TBL] [Abstract][Full Text] [Related]
10. New generation ENaC inhibitors detach cystic fibrosis airway mucus bundles via sodium/hydrogen exchanger inhibition.
Giorgetti M; Klymiuk N; Bähr A; Hemmerling M; Jinton L; Tarran R; Malmgren A; Åstrand A; Hansson GC; Ermund A
Eur J Pharmacol; 2021 Aug; 904():174123. PubMed ID: 33974881
[TBL] [Abstract][Full Text] [Related]
11. Loss of Cftr function exacerbates the phenotype of Na(+) hyperabsorption in murine airways.
Livraghi-Butrico A; Kelly EJ; Wilkinson KJ; Rogers TD; Gilmore RC; Harkema JR; Randell SH; Boucher RC; O'Neal WK; Grubb BR
Am J Physiol Lung Cell Mol Physiol; 2013 Apr; 304(7):L469-80. PubMed ID: 23377346
[TBL] [Abstract][Full Text] [Related]
12. Hypoxic epithelial necrosis triggers neutrophilic inflammation via IL-1 receptor signaling in cystic fibrosis lung disease.
Fritzsching B; Zhou-Suckow Z; Trojanek JB; Schubert SC; Schatterny J; Hirtz S; Agrawal R; Muley T; Kahn N; Sticht C; Gunkel N; Welte T; Randell SH; Länger F; Schnabel P; Herth FJ; Mall MA
Am J Respir Crit Care Med; 2015 Apr; 191(8):902-13. PubMed ID: 25607238
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic options for hydrating airway mucus in cystic fibrosis.
Tildy BE; Rogers DF
Pharmacology; 2015; 95(3-4):117-32. PubMed ID: 25823699
[TBL] [Abstract][Full Text] [Related]
14. Cystic fibrosis: a disease of vulnerability to airway surface dehydration.
Boucher RC
Trends Mol Med; 2007 Jun; 13(6):231-40. PubMed ID: 17524805
[TBL] [Abstract][Full Text] [Related]
15. CFTR, mucins, and mucus obstruction in cystic fibrosis.
Kreda SM; Davis CW; Rose MC
Cold Spring Harb Perspect Med; 2012 Sep; 2(9):a009589. PubMed ID: 22951447
[TBL] [Abstract][Full Text] [Related]
16. Mucus obstruction and inflammation in early cystic fibrosis lung disease: Emerging role of the IL-1 signaling pathway.
Balázs A; Mall MA
Pediatr Pulmonol; 2019 Nov; 54 Suppl 3():S5-S12. PubMed ID: 31715090
[TBL] [Abstract][Full Text] [Related]
17. CFTR delivery to 25% of surface epithelial cells restores normal rates of mucus transport to human cystic fibrosis airway epithelium.
Zhang L; Button B; Gabriel SE; Burkett S; Yan Y; Skiadopoulos MH; Dang YL; Vogel LN; McKay T; Mengos A; Boucher RC; Collins PL; Pickles RJ
PLoS Biol; 2009 Jul; 7(7):e1000155. PubMed ID: 19621064
[TBL] [Abstract][Full Text] [Related]
18. SPX-101 Is a Novel Epithelial Sodium Channel-targeted Therapeutic for Cystic Fibrosis That Restores Mucus Transport.
Scott DW; Walker MP; Sesma J; Wu B; Stuhlmiller TJ; Sabater JR; Abraham WM; Crowder TM; Christensen DJ; Tarran R
Am J Respir Crit Care Med; 2017 Sep; 196(6):734-744. PubMed ID: 28481660
[TBL] [Abstract][Full Text] [Related]
19. Immunopathology of Airway Surface Liquid Dehydration Disease.
Lewis BW; Patial S; Saini Y
J Immunol Res; 2019; 2019():2180409. PubMed ID: 31396541
[TBL] [Abstract][Full Text] [Related]
20. Hypertonic saline is effective in the prevention and treatment of mucus obstruction, but not airway inflammation, in mice with chronic obstructive lung disease.
Graeber SY; Zhou-Suckow Z; Schatterny J; Hirtz S; Boucher RC; Mall MA
Am J Respir Cell Mol Biol; 2013 Sep; 49(3):410-7. PubMed ID: 23590312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
